RNA Details
                    Disease Name
                    
                    pulmonary fibrosis
                    
                    Tissue
                    
                    lung
                    
                    RNA Symbol
                    
                    miR-486-5p
                    
                RNA ID
                    
                    
                    
                RNA Type
                    
                    miRNA
                    
                Alteration Pattern
                    
                    down regulation
                    
                Species
                    
                    mus musculus
                    
                Detection Methods
                    
                    qRT-PCR; Dual-luciferase reporter assay; Immunoblot etc.
                    
                Target
                    
                    Smad2
                    
                Pathway
                    
                    NA
                    
                PubMed ID
                    
                    
                    
                    
                    
                Title
                    
                    The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis
                    
                Year
                    
                     2015
                    
                Function
                    
                    "The dysregulation of five miRNAs, including miR-21, miR-455, miR-151-3p, miR-486-5p and miR-3107, were confirmed by qRT-PCRs in silica-induced mouse model of pulmonary fibrosis and were also confirmed in a bleomycin (BLM)-induced mouse lung fibrosis. Notably, miR-486-5p levels were decreased in the serum samples of patients with silicosis, as well as in the lung tissues of patients with silicosis and idiopathic pulmonary fibrosis (IPF). SMAD2 was identified to be one of target genes of miR-486-5p. MiR-486-5p expression significantly decreased both the distribution and severity of lung lesions compared with the silica group (P < 0.01)."